Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Zhongguo Zhong Yao Za Zhi ; 48(19): 5235-5243, 2023 Oct.
Artigo em Chinês | MEDLINE | ID: mdl-38114112

RESUMO

The aim of this study is to investigate the effects of Gynostemma pentaphyllum dried with two different methods(air drying and heating) on inflammation in acute lung injury(ALI) mice in vivo and in vitro. Lipopolysaccharide(LPS) was sprayed into the airway of wild type C57BL/6J male mice to establish the model, and the drug was injected into the tail vein 24 h after modeling. Lung function, lung tissue wet/dry weight(W/D) ratio, the total protein concentration, interleukin 6(IL-6), IL-1ß, and tumor necrosis factor-α(TNF-α) in the bronchoalveolar lavage fluid(BALF), and pathological changes of the lung tissue were used to evaluate the effects of different gypenosides on ALI mice. The results showed that total gypenosides(YGGPs) and the gypenosides substituted with one or two glycosyl(GPs_(1-2)) in the air-dried sample improved the lung function, significantly lowered the levels of IL-1ß and TNF-α in BALF, and alleviated the lung inflammation of ALI mice. Moreover, GPs_(1-2) had a more significant effect on inhibiting NO release in RAW264.7 cells. This study showed that different drying methods affected the anti-inflammatory activity of G. pentaphyllum, and the rare saponins in the air-dried sample without heating had better anti-inflammatory activity.


Assuntos
Gynostemma , Fator de Necrose Tumoral alfa , Masculino , Camundongos , Animais , Fator de Necrose Tumoral alfa/metabolismo , Camundongos Endogâmicos C57BL , Pulmão , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/metabolismo , Interleucina-6/metabolismo , Interleucina-1beta/genética , Interleucina-1beta/metabolismo , Lipopolissacarídeos/farmacologia
2.
J Spinal Cord Med ; 46(5): 798-806, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-35792817

RESUMO

PURPOSE: Warm acupuncture (WA) therapy has been applied to treat spinal cord injury (SCI), but the underlying mechanism is unclear. The current study attempted to explore the WA therapy on neuronal apoptosis of SCI and the relationship with the extracellular signal-regulated kinase (ERK) signaling pathway. METHODS: The rat SCI models were established by the impact method. SCI rat models were subjected to WA treatment at Dazhui (GV14) and Jiaji points (T10), Yaoyangguan (GV3), Zusanli (ST36), and Ciliao (BL32). The rat SCI models were established by the impact method. WA and U0126 treatments were performed on the SCI rats. Motor function and neuronal apoptosis were detected. The relative mRNA of tumor necrosis factor-α (TNF-α), interleukin-1ß (IL-1ß), and interleukin-6 (IL-6), the phosphorylation level of ERK 1/2 and levels of B-cell lymphoma-2 (Bcl-2), BCL2-Associated X (Bax), and caspase-3 in spinal cord tissue were tested. RESULTS: After WA treatment, the Basso, Beattie & Bresnahan locomotor rating scale (BBB scale) of SCI rats in the WA treatment was significantly raised from 7 to 14 days after SCI. WA and U0126 treatment significantly diminished apoptotic cells and preserved the neurons in the injured spinal cord. WA and U0126 treatment alleviated the production of inflammatory cytokines in the spinal cord. The distinct increase of p-ERK 1/2 induced by SCI was reversed in WA and U0126 treatment groups. WA and U0126 treatment augmented the level of Bcl-2 and reversed the elevated cleaved caspase-3 protein level after SCI. CONCLUSION: Our study demonstrated that WA might be associated with the downregulation of the ERK signaling pathway. In summary, our findings indicated that WA promotes the recovery of SCI via the protection of nerve cells and the prevention of apoptosis. Meanwhile, the anti-apoptotic effect of WA might be associated with the downregulation of the ERK signaling pathway, which could be one of the mechanisms of WA in the treatment of SCI.


Assuntos
Terapia por Acupuntura , Traumatismos da Medula Espinal , Animais , Ratos , Apoptose , Caspase 3/metabolismo , Caspase 3/farmacologia , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , MAP Quinases Reguladas por Sinal Extracelular/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/farmacologia , Ratos Sprague-Dawley , Recuperação de Função Fisiológica/fisiologia , Transdução de Sinais , Medula Espinal/patologia , Traumatismos da Medula Espinal/patologia , Traumatismos da Medula Espinal/terapia
3.
J Spinal Cord Med ; 45(1): 106-116, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-32441569

RESUMO

Objective: Acupuncture combined with moxibustion (AM) therapy has been applied to treat spinal cord injury (SCI), but the underlying mechanism is unclear. The present study aimed to confirm the effect and mechanism of AM treatment on the recovery of SCI.Design: Male Sprague-Dawley rats were used to establish the SCI model by impact method. SCI rat models were subjected to AM treatment at Dazhui (GV14) and Jiaji points (T7-T12), Yaoyangguan (GV3), Zusanli (ST36) and Ciliao (BL32).Outcome measures: Motor function and cell apoptosis in rats after SCI. The mRNA and protein expression levels of Shh and Gli-1 were determined by real-time quantitative polymerase chain reaction, western blot and immunohistochemistry.Results: After AM treatment, the hindlimb motor function of SCI rats was significantly increased than the SCI group at 7, 9, 11, 14 days (P < 0.05). AM treatment 7 d and 14 d significantly preserved the nissl-stained positive neurons and significantly decreased number of apoptotic cells, compared to that of SCI 7 and 14 d groups (P < 0.05). AM treatment improved the mRNA protein levels of Shh and Gli-1 after 7 and 14 days treatment compared to the SCI group (P < 0.05).Conclusion: AM could improve the expression of Shh and Gli-1 in injured spinal cord of rats. That could be part of underlying mechanisms of AM treatment including recover motor function and preserve the neuron cells and alleviate the apoptosis of nerve cells in rats after SCI.


Assuntos
Terapia por Acupuntura , Moxibustão , Traumatismos da Medula Espinal , Animais , Proteínas Hedgehog/genética , Proteínas Hedgehog/metabolismo , Humanos , Masculino , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Recuperação de Função Fisiológica , Transdução de Sinais , Medula Espinal
4.
Neuropsychiatr Dis Treat ; 15: 3429-3442, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31997879

RESUMO

PURPOSE: To observe the changes of Nogo/NgR and Rho/ROCK signaling pathway-related gene and protein expression in rats with spinal cord injury (SCI) treated with electroacupuncture (EA) and to further investigate the possible mechanism of EA for treating SCI. METHODS: Allen's method was used to create the SCI rat model. Sixty-four model rats were further subdivided into four subgroups, namely, the SCI model group (SCI), EA treatment group (EA), blocking agent Y27632 treatment group (Y27632) and EA+blocking agent Y27632 treatment group (EA+Y), according to the treatment received. The rats were subjected to EA and/or blocking agent Y27632 treatment. After 14 days, injured spinal cord tissue was extracted for analysis. The mRNA and protein expression levels were determined by real-time fluorescence quantitative PCR and Western blotting, respectively. Cell apoptosis changes in the spinal cord were evaluated by in situ hybridization. Hindlimb motor function in the rats was evaluated by Basso-Beattie-Bresnahan assessment methods. RESULTS: Except for RhoA protein expression, compared with the SCI model group, EA, blocking agent Y27632 and EA+blocking agent Y27632 treatment groups had significantly reduced mRNA and protein expression of Nogo-A, NgR, LINGO-1, RhoA and ROCK II in spinal cord tissues, increased mRNA and protein expression of MLCP, decreased p-MYPT1 protein expression and p-MYPT1/MYPT1 ratio, and caspase3 expression, and improved lower limb movement function after treatment for 14 days (P<0.01 or <0.05). The combination of EA and the blocking agent Y27632 was superior to EA or blocking agent Y27632 treatment alone (P < 0.01 or <0.05). CONCLUSION: EA may have an obvious inhibitory effect on the Nogo/NgR and Rho/ROCK signaling pathway after SCI, thereby reducing the inhibition of axonal growth, which may be a key mechanism of EA treatment for SCI.

5.
Huan Jing Ke Xue ; 39(4): 1782-1793, 2018 Apr 08.
Artigo em Chinês | MEDLINE | ID: mdl-29965005

RESUMO

In this paper, the performance, characteristics of the bulking sludge, and the variations in the microbial community (including the bulking bacteria) under different nitrogen and phosphorus imbalances were compared, using high-throughput sequencing (16S rRNA) and the high performance liquid chromatography (HPLC) technology. The results showed that after seeding bulking sludge in the A/O process and operating for a period of time, the sludge settleability of the nitrogen limitation alone reactor (RN) could recover to normal[sludge volume index (SVI)<150 mL·g-1], while the SVI of the phosphorus limitation alone reactor (RP) improved slightly; the control reactor (R0, C/N/P=100/5/1) exhibited the highest SVI index (SVI=1496 mL·g-1), followed by the reactor of simultaneous nitrogen and phosphorus limitations (RNP). Under normal nutritional conditions, Pearson correlation analysis showed a significant negative correlation between the lipopolysaccharide (LPS) relative content (LPS/MLVSS) and the settleability of bulking sludge (r=-0.625, P<0.05), while under nutrient limitation conditions, LPS showed high accuracy in reflecting the biomass of the activated sludge. Thiothrix was the dominant bulking bacteria in all the reactors. PCoA analysis showed that the migration of the community in the reactors experienced nitrogen limitation (RNP, RN) changes greatly during the stages Ⅱ and Ⅲ, while RDA analysis showed that the correlation of Thiothrix with the settling performance and oxygen consumption rate was significant.


Assuntos
Bactérias/classificação , Reatores Biológicos/microbiologia , Nitrogênio/química , Fósforo/química , Esgotos/microbiologia , Bactérias/metabolismo , RNA Ribossômico 16S/genética , Eliminação de Resíduos Líquidos
6.
Neural Regen Res ; 12(2): 276-282, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28400811

RESUMO

Electroacupuncture is beneficial for the recovery of spinal cord injury, but the underlying mechanism is unclear. The Rho/Rho-associated kinase (ROCK) signaling pathway regulates the actin cytoskeleton by controlling the adhesive and migratory behaviors of cells that could inhibit neurite regrowth after neural injury and consequently hinder the recovery from spinal cord injury. Therefore, we hypothesized electroacupuncture could affect the Rho/ROCK signaling pathway to promote the recovery of spinal cord injury. In our experiments, the spinal cord injury in adult Sprague-Dawley rats was caused by an impact device. Those rats were subjected to electroacupuncture at Yaoyangguan (GV3), Dazhui (GV14), Zusanli (ST36) and Ciliao (BL32) and/or monosialoganglioside treatment. Behavioral scores revealed that the hindlimb motor functions improved with those treatments. Real-time quantitative polymerase chain reaction, fluorescence in situ hybridization and western blot assay showed that electroacupuncture suppressed the mRNA and protein expression of Rho-A and Rho-associated kinase II (ROCKII) of injured spinal cord. Although monosialoganglioside promoted the recovery of hindlimb motor function, monosialoganglioside did not affect the expression of Rho-A and ROCKII. However, electroacupuncture combined with monosialoganglioside did not further improve the motor function or suppress the expression of Rho-A and ROCKII. Our data suggested that the electroacupuncture could specifically inhibit the activation of the Rho/ROCK signaling pathway thus partially contributing to the repair of injured spinal cord. Monosialoganglioside could promote the motor function but did not suppress expression of RhoA and ROCKII. There was no synergistic effect of electroacupuncture combined with monosialoganglioside.

7.
World J Gastroenterol ; 21(16): 4852-63, 2015 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-25944998

RESUMO

AIM: To determine the molecular mechanisms of Shugan decoction (SGD) in the regulation of colonic motility and visceral hyperalgesia (VHL) in irritable bowel syndrome (IBS). METHODS: The chemical compounds contained in SGD were measured by high-performance liquid chromatography. A rat model of IBS was induced by chronic water avoidance stress (WAS). The number of fecal pellets was counted after WAS and the pain pressure threshold was measured by colorectal distension. Morphological changes in colonic mucosa were detected by hematoxylin-eosin staining. The contents of tumor necrosis factor (TNF)-α in colonic tissue and calcitonin-gene-related peptide (CGRP) in serum were measured by ELISA. The protein expression of serotonin [5-hydroxytryptamide (5-HT)], serotonin transporter (SERT), chromogranin A (CgA) and CGRP in colon tissue was measured by immunohistochemistry. RESULTS: SGD inhibited colonic motility dysfunction and VHL in rats with IBS. Blockers of transient receptor potential (TRP) vanilloid 1 (TRPV1) (Ruthenium Red) and TRP ankyrin-1 (TRPA1) (HC-030031) and activator of protease-activated receptor (PAR)4 increased the pain pressure threshold, whereas activators of PAR2 and TRPV4 decreased the pain pressure threshold in rats with IBS. The effect of SGD on pain pressure threshold in these rats was abolished by activators of TRPV1 (capsaicin), TRPV4 (RN1747), TRPA1 (Polygodial) and PAR2 (AC55541). In addition, CGRP levels in serum and colonic tissue were both increased in these rats. TNF-α level in colonic tissue was also significantly upregulated. However, the levels of 5-HT, SERT and CgA in colonic tissue were decreased. All these pathological changes in rats with IBS were attenuated by SGD. CONCLUSION: SGD alleviated VHL and attenuated colon motility in IBS, partly by regulating TRPV1, TRPV4, TRPA1, PAR2, 5-HT, CgA and SERT, and reducing CGRP and TNF-α level.


Assuntos
Colo/efeitos dos fármacos , Medicamentos de Ervas Chinesas/farmacologia , Motilidade Gastrointestinal/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Síndrome do Intestino Irritável/tratamento farmacológico , Receptor PAR-2/efeitos dos fármacos , Serotonina/metabolismo , Canais de Potencial de Receptor Transitório/efeitos dos fármacos , Animais , Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Cromogranina A/metabolismo , Colo/inervação , Colo/metabolismo , Modelos Animais de Doenças , Hiperalgesia/tratamento farmacológico , Hiperalgesia/metabolismo , Hiperalgesia/fisiopatologia , Mucosa Intestinal/inervação , Mucosa Intestinal/metabolismo , Síndrome do Intestino Irritável/metabolismo , Síndrome do Intestino Irritável/fisiopatologia , Masculino , Limiar da Dor/efeitos dos fármacos , Pressão , Proteínas de Ligação a RNA/metabolismo , Ratos Sprague-Dawley , Receptor PAR-2/metabolismo , Transdução de Sinais/efeitos dos fármacos , Fatores de Tempo , Canais de Potencial de Receptor Transitório/metabolismo , Fator de Necrose Tumoral alfa/metabolismo
8.
Yao Xue Xue Bao ; 47(8): 1006-10, 2012 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-23162896

RESUMO

The study is to report the investigation of the effects of isorhamnetin on CYP3A4 and herb-drug interaction. A reporter gene assay is used to test pregnane X receptor transactivation action, qRT-PCR and a luminescence-based assay were applied to determine mRNA induction and enzyme activity of CYP3A4 after isorhamnetin treatment. The interaction of irinotecan and isorhamnetin was assessed by inhibition assay of cell proliferation. Isorhamnetin at 1, 10 and 25 micromol x L(-1) transactivated the CYP3A4 reporter construct and upregulated CYP3A4 mRNA as well in a dose-dependent manner. However, isorhamnetin had no effect on enzyme activity of CYP3A4 and irinotecan HepG2 cytotoxicity. In conclusion, activation of PXR by isorhamnetin played a role in the upregulation of CYP3A4 mRNA. Moreover, joint action of isorhamnetin with other drugs may not be associated with the herb-drug interaction.


Assuntos
Camptotecina/análogos & derivados , Proliferação de Células/efeitos dos fármacos , Citocromo P-450 CYP3A/metabolismo , Interações Ervas-Drogas , Quercetina/análogos & derivados , Antineoplásicos Fitogênicos/farmacologia , Camptotecina/farmacologia , Citocromo P-450 CYP3A/genética , Relação Dose-Resposta a Droga , Células Hep G2 , Humanos , Irinotecano , Receptor de Pregnano X , Quercetina/administração & dosagem , Quercetina/farmacologia , RNA Mensageiro/metabolismo , Receptores de Esteroides/metabolismo , Ativação Transcricional/efeitos dos fármacos , Regulação para Cima
9.
J Ethnopharmacol ; 140(2): 222-9, 2012 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-22274634

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Danning tablet, as a composite prescription of traditional Chinese medicine, has been used clinically to relieve liver and gallbladder diseases in China. However, the mechanisms involved are still unclear. AIM OF THE STUDY: The present investigation was designed to assess the effects and possible mechanisms of Danning tablet on α-naphthylisothiocyanate (ANIT)-induced liver injury with cholestasis. MATERIALS AND METHODS: Danning tablet (3, 1.5 or 0.75g/kg body weight/day) was intragastrically (i.g.) given to experimental rats for seven days before they were treated with ANIT (60mg/kg daily via i.g.) which caused liver injury. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyltranspeptidase (γ-GTP), total bilirubin (T-Bil), direct bilirubin (D-Bil), total bile acid (TBA) and bile flow were measured to evaluate the protective effect of Danning tablet at 48h after ANIT treatment. Furthermore, protective mechanisms of Danning tablet against ANIT-induced liver injury were elucidated by assays of liver enzyme activities and component contents including myeloperoxidase (MPO), superoxide dismutase (SOD), glutathione peroxidase (Gpx), catalase (CAT) and glutathione S-transferase (GST), as well as liver lipid peroxide (LPO) and glutathione (GSH). The biochemical observations were supplemented by histopathological examination. Phytochemical analysis of Danning tablet was performed by UPLC-MASS. RESULTS: Obtained results demonstrated that high dose (3g/kg) of Danning tablet significantly prevented ANIT-induced changes in bile flow (P<0.01), and serum levels of ALT, AST, ALP, γ-GTP, T-Bil, D-Bil (P<0.01) and TBA (P<0.05). In addition, ANIT-induced increases in hepatic MPO, GST activities and GSH, LPO contents were significantly (P<0.01) reduced, while SOD, Gpx, CAT activities in the liver tissue which were suppressed by ANIT were significantly (P<0.01) elevated in the groups pretreated with Danning tablet at the dose of 3g/kg B.W. Histopathology of the liver tissue showed that pathological injuries were relieved after Danning tablet (3g/kg) pretreatment. The results also showed that medium dose (1.5g/kg) of Danning tablet exhibited partially protective effect on ANIT-induced liver injury with cholestasis by reversing part of biochemical parameters and histopathological changes. Low dose (0.75g/kg) of Danning tablet did not show any protective effect on ANIT-induced liver injury with cholestasis. Phytochemical analyses revealed the presence of anthraquinones, flavonoids and stilbene in the Danning tablet. CONCLUSION: These findings indicate that Danning tablet exerts a dose-dependently protective effect on ANIT-induced liver injury with cholestasis in rats, and the possible mechanism of this activity is likely due to its attenuation of oxidative stress in the liver tissue and neutrophil infiltration.


Assuntos
Antioxidantes/uso terapêutico , Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Colestase/prevenção & controle , Medicamentos de Ervas Chinesas/uso terapêutico , Fígado/efeitos dos fármacos , Magnoliopsida/química , Fitoterapia , 1-Naftilisotiocianato , Doença Aguda , Animais , Antraquinonas/análise , Antraquinonas/farmacologia , Antraquinonas/uso terapêutico , Antioxidantes/farmacologia , Bile/metabolismo , Bilirrubina/sangue , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Doença Hepática Induzida por Substâncias e Drogas/patologia , Colestase/induzido quimicamente , Colestase/metabolismo , Colestase/patologia , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas/química , Medicamentos de Ervas Chinesas/farmacologia , Flavonoides/análise , Flavonoides/farmacologia , Flavonoides/uso terapêutico , Fígado/metabolismo , Fígado/patologia , Masculino , Infiltração de Neutrófilos/efeitos dos fármacos , Ratos Wistar , Estilbenos/análise , Estilbenos/farmacologia , Estilbenos/uso terapêutico , Transaminases/sangue
10.
Zhongguo Zhong Yao Za Zhi ; 32(18): 1893-5, 2007 Sep.
Artigo em Chinês | MEDLINE | ID: mdl-18051899

RESUMO

OBJECTIVE: To study the chemical constituents of root of Actinidia macrosperma. METHOD: Chromatographic methods were used to isolate compounds from A. macrosperma and spectroscopic methods were used to identify the structures of the isolated compounds. RESULT: Eight compounds were obtained and identified as 12-oleanene-2alpha, 3alpha, 24-triol (1), isotachioside (2), asiatic acid (3), catechin (4), epicatechin (5), ursolic acid (6), beta-daucosterol (7), beta-sitosterol (8). CONCLUSION: All these compounds were isolated from this plant for the first time, compound 1, 2 were obtained from this genus for the first time.


Assuntos
Actinidia/química , Catequina/isolamento & purificação , Glucosídeos/isolamento & purificação , Hidroquinonas/isolamento & purificação , Ácido Oleanólico/análogos & derivados , Raízes de Plantas/química , Triterpenos/isolamento & purificação , Catequina/química , Glucosídeos/química , Hidroquinonas/química , Ácido Oleanólico/química , Ácido Oleanólico/isolamento & purificação , Triterpenos Pentacíclicos , Plantas Medicinais/química , Triterpenos/química
11.
Zhongguo Zhong Yao Za Zhi ; 31(20): 1661-4, 2006 Oct.
Artigo em Chinês | MEDLINE | ID: mdl-17225527

RESUMO

The collected information is an attempt to cover the more recent developments in the phytochemistry and pharmacology of this genus. During the past years, alkaloids, flavonoids, volatile oils, organic acids, polysaccharides, tannins and phenolic constituents have been isolated from Ephedra. Pharmacological studies are described according to hypoglycemic effects, anticoagulated blood properties, depressurization, immunosuppressive activity, antioxidation and antivirus activity and so on. The information summarized here is intended to provid a rational foundation for the futher development and utilization of Ephedra which is rich in China.


Assuntos
Ephedra/química , Hipoglicemiantes/farmacologia , Imunossupressores/farmacologia , Plantas Medicinais/química , Polissacarídeos/isolamento & purificação , Alcaloides/química , Alcaloides/isolamento & purificação , Animais , Ephedra/classificação , Flavonoides/química , Flavonoides/isolamento & purificação , Estrutura Molecular , Caules de Planta/química , Polissacarídeos/farmacologia
12.
Yao Xue Xue Bao ; 40(2): 105-10, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15875663

RESUMO

AIM: To investigate the inhibitory effects and mechanism of action of isoliensinine (IL) on the proliferation of porcine coronary arterial smooth muscle cells (CASMCs) induced by phenylephrine (Phen) and its mechanisms of action. METHODS: MTT assay, immunohistochemical method and Western blotting were adopted. RESULTS: IL (0.03 - 3 micromol x L(-1)) could inhibit the CASMCs proliferation induced by Phen (0.1 micromol x L(-1)) in a concentration-dependent manner. IL (0.1 micromol x L(-1)) antagonized Phen-induced overexpression of PDGF-beta and bFGF from 0.545 +/- 0.026 and 0.47 +/- 0.03 to 0.458 +/- 0.019 and 0.376 +/- 0.017 (P < 0.01 , P < 0.01). IL (0.1 micromol x L(-1)) also decreased c-fos, c-myc and hsp70 overexpression induced by Phen from 0.57 +/- 0.04, 0.44 +/- 0.04 and (173 +/- 36)% to 0.46 +/- 0.05, 0.372 +/- 0.021 and (115 +/- 35)% respectively (P < 0.01, P < 0.01, P < 0.01). CONCLUSION: IL exerted antiproliferative effect on CASMCs induced by phenylephrine, and its mechanisms were related to decrease the overexpression of growth factors (PDGF-beta, bFGF), protooncogene (c-fos, c-myc) and hsp70.


Assuntos
Proliferação de Células/efeitos dos fármacos , Isoquinolinas/farmacologia , Músculo Liso Vascular/citologia , Animais , Células Cultivadas , Vasos Coronários/citologia , Relação Dose-Resposta a Droga , Fator 2 de Crescimento de Fibroblastos/metabolismo , Proteínas de Choque Térmico HSP70/metabolismo , Isoquinolinas/administração & dosagem , Isoquinolinas/isolamento & purificação , Nelumbo/química , Fenilefrina/antagonistas & inibidores , Plantas Medicinais/química , Proteínas Proto-Oncogênicas c-fos/metabolismo , Proteínas Proto-Oncogênicas c-myc/metabolismo , Proteínas Proto-Oncogênicas c-sis/metabolismo , Suínos
13.
Zhongguo Zhong Yao Za Zhi ; 27(7): 531-4, 2002 Jul.
Artigo em Chinês | MEDLINE | ID: mdl-12776518

RESUMO

OBJECTIVE: To explore the immuno-neurologic regulation of hypertension and its inherent law as well as the mechanisms of curing and systemic regulating effect of ZiShuiJiangHuoYin(ZSJHY). METHOD: To detect expression level of AT-1mRNA in two-kidney-one-clamp renal hypertension rat lymphocyte cell by means of RT-PCR. RESULT: The level of AT-1 mRNA in lymphocyte was higher in group of 2K1C-RHR than that in normal group. ZSJHY (20 g/kg, 40 g/kg) had regulating effect on this. CONCLUSION: Depressing excessive expression of lymphocyte AT-1 mRNA may be one of the mechanisms where ZSJHY exert immunoregulation action.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Hipertensão Renovascular/metabolismo , Linfócitos/metabolismo , Plantas Medicinais/química , Receptores de Angiotensina/biossíntese , Animais , Combinação de Medicamentos , Medicamentos de Ervas Chinesas/isolamento & purificação , Masculino , RNA Mensageiro/genética , Ratos , Ratos Wistar , Receptores de Angiotensina/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA